PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 211 (xsd:integer)
nif:isString
  • Skin toxicity is the most common adverse event (AE) related to vemurafenib, affecting more than 90% of patients.4 5 Grade 3 skin toxicity is observed in a variable percentage from 15% to 40% of treated patients.
rdf:type